The clearances for the conduct of the country’s eight month-long Ivermectin clinical trial are expected to be released within this month, the Department of Science and Technology (DOST) said Friday, Jan. 7.
Ivermectin pills (Photo courtesy of IndiaMart via PNA)
“All clearances are...
The Department of Science and Technology (DOST) has explained why the country’s eight month-long clinical trial seeking to assess the efficacy, safety, and effect on viral clearance of anti-parasitic drug Ivermectin in asymptomatic and mild coronavirus disease (COVID-19) patients confined in...
The Department of Science and Technology (DOST) said the “latest protocol" for the country’s eight month-long clinical trials seeking to assess the efficacy, safety, and effect on viral clearance of anti-parasitic drug Ivermectin in asymptomatic and mild coronavirus disease (COVID-19) patients...
The Department of Science and Technology (DOST) said Sunday, Oct. 31, that the eight month-long clinical trials seeking to assess the efficacy, safety, and effect on viral clearance of anti-parasitic drug Ivermectin in asymptomatic and mild coronavirus disease (COVID-19) patients confined in...
The Department of Science and Technology (DOST) said Saturday, Oct. 23, said the recruitment of over 1,400 participants for the eight month-long clinical Ivermectin clinical trials is expected to start in November, and that the initial results of the study may be out by end of December this year.
...
Bracing for “good results,” the Department of Science and Technology (DOST) said Thursday, Oct. 21, that the drug developers and the public are expected to benefit from the country’s clinical trials seeking to assess the efficacy, safety, and effect on viral clearance of anti-parasitic drug...
The Philippines will produce its own Ivermectin capsule, the Department of Science and Technology (DOST) said Sunday, Oct. 17.
(MANILA BULLETIN FILE PHOTO)
DOST Undersecretary for Research and Development (R&D) Rowena Cristina Guevara said the University of the Philippines (UP) Manila...
The country’s clinical trials seeking to assess the efficacy, safety, and effect on viral clearance of anti-parasitic drug Ivermectin in asymptomatic and mild coronavirus disease (COVID-19) patients confined in isolation facilities will begin on Oct. 15, the Department of Science and Technology...
Ivermectin (MB/FILE PHOTO)
The Department of Health (DOH) reminded the public that antiparasitic drug Ivermectin is still not recommended as a possible treatment for coronavirus disease (COVID).
DOH Undersecretary Maria Rosario Vergeire made the statement as she cited the recommendation of the...
The clinical trial on the use of anti-parasitic drug Ivermectin for COVID-19 patients in the country has been moved again for one more month, from Sept. 15 to Oct. 15, due to ongoing revisions on its protocols.
Department of Science and Technology (DOST) Sec. Fortunato Dela Peña said in a...
As the debate on its effectiveness in treating coronavirus (COVID-19) continues, President Duterte has decided to leave the use of antiparasitic drug ivermectin to the discretion of doctors and patients.
File photos
Duterte made the statement as the clinical studies on ivermectin as a cure for...
The country’s eight month-long study on the use of anti-parasitic drug Ivermectin as a treatment for coronavirus disease (COVID-19) is set to begin on Sept. 15, the Department of Science and Technology (DOST) said Friday, Aug. 27.
(MANILA BULLETIN FILE PHOTO)
DOST Undersecretary for...
